| Impact of the carotenoid astaxanthin on phagocytic capacity and ROS/RNS production of human neutrophils treated with free fatty acids and high glucose. | |
| | |
MedLine Citation:
|
PMID: 22008307 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: The purpose of the present study was to evaluate the effect of carotenoid astaxanthin (ASTA) on human neutrophils treated with high glucose and free fatty acids (FFA) on the phagocytic capacity and reactive oxygen/nitrogen species production. METHODS: The following parameters were evaluated: phagocytic capacity of neutrophils by using zymosan particles, intracellular and extracellular superoxide anion (lucigenin and DHE probes), hydrogen peroxide (H(2)O(2) - phenol red), nitric oxide (Griess reagent) production, and maximal activity of G6PDH. RESULTS: There was a decreased phagocytic capacity of human neutrophils treated with high glucose (30mM) or FFA (0.1mM) and a partial restoring of the phagocytic capacity after ASTA-treatment was observed. ROS and RNS production was increased in neutrophils due to both high glucose and FFA. This increase in ROS/RNS production was also partially prevented by ASTA treatment. Both glucose and FFA increased the G6PDH activity. We show that ASTA provides a modest improvement of cellular functions after cells have been treated with high glucose and FFA. CONCLUSIONS: In summary, this study showed that both high glucose and a mixture of FFA are potent inducers of ROS/RNS production on neutrophils as observed by higher levels of superoxide anion, hydrogen peroxide and NO production. Also, these metabolites decrease the phagocytic capacity of neutrophils and increase the G6PDH activity. Overall, ASTA-treatment was able to reduce partially ROS/RNS production by reducing the availability of NADPH and recover phagocytic capacity of neutrophils. |
| | |
Authors:
|
Beatriz Alves Guerra; Rosemari Otton |
Related Documents
:
|
21752377 - Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated athero... 21703397 - Dual blockade of the homeostatic chemokine cxcl12 and the proinflammatory chemokine ccl... 20393187 - Optimal control of blood glucose: the diabetic patient or the machine? 14582657 - Evaluation of a continuous glucose monitoring system in diabetic dogs. 19587367 - Cystatin c, albuminuria, and mortality among older adults with diabetes. 18390927 - Priming of neutrophil oxidative burst in diabetes requires preassembly of the nadph oxi... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-10-15 |
Journal Detail:
|
Title: International immunopharmacology Volume: - ISSN: 1878-1705 ISO Abbreviation: - Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-10-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100965259 Medline TA: Int Immunopharmacol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011. Published by Elsevier B.V. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Selenium inhibits migration of murine melanoma cells via down-modulation of IL-18 expression.
Next Document: Practice guidelines need to address the 'how' and the 'what' of implementation.